Association of Nuclear Receptor Coactivators with Hypoxia-Inducible Factor-1
Journal
BioMed research international
ISSN: 2314-6141
Titre abrégé: Biomed Res Int
Pays: United States
ID NLM: 101600173
Informations de publication
Date de publication:
2020
2020
Historique:
received:
03
03
2020
revised:
29
05
2020
accepted:
04
08
2020
entrez:
5
9
2020
pubmed:
5
9
2020
medline:
24
4
2021
Statut:
epublish
Résumé
Nuclear receptor coactivators (NCOAs), consisting of coactivators and corepressors, dramatically enhance the transcriptional activity of nuclear receptors. Hypoxia-inducible factor-1
Identifiants
pubmed: 32884936
doi: 10.1155/2020/1587915
pmc: PMC7455818
doi:
Substances chimiques
HIF1A protein, human
0
Hypoxia-Inducible Factor 1, alpha Subunit
0
Nuclear Receptor Coactivators
0
VEGFA protein, human
0
Vascular Endothelial Growth Factor A
0
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1587915Informations de copyright
Copyright © 2020 Tianbiao Zhou et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
J Cell Biochem. 2019 May;120(5):8483-8491
pubmed: 30556156
Acta Histochem. 2019 Aug;121(6):695-703
pubmed: 31239073
J Cell Mol Med. 2020 Feb;24(3):2178-2188
pubmed: 31930683
Life Sci. 2020 Jan 15;241:117109
pubmed: 31786195
Evid Based Complement Alternat Med. 2019 Jul 2;2019:7656105
pubmed: 31354858
JAMA Intern Med. 2019 Dec 9;:
pubmed: 31816007
Histopathology. 2018 Dec;73(6):990-1001
pubmed: 30014486
Cell Death Dis. 2020 Jan 13;11(1):26
pubmed: 31932578
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Sci Rep. 2019 Oct 31;9(1):15762
pubmed: 31673032
Oxid Med Cell Longev. 2019 Aug 28;2019:9219847
pubmed: 31558952
Annu Rev Med. 2014;65:279-92
pubmed: 24111892
Psychoneuroendocrinology. 2009 Dec;34 Suppl 1:S9-19
pubmed: 19541426
Biochemistry. 2011 Jan 25;50(3):313-28
pubmed: 21141906
Saudi Med J. 2018 Jun;39(6):586-591
pubmed: 29915853
Am J Respir Cell Mol Biol. 2018 Jul;59(1):114-126
pubmed: 29394091
Oncotarget. 2017 Sep 4;8(44):76622-76633
pubmed: 29100336
Int J Mol Sci. 2018 Jun 24;19(7):
pubmed: 29937525
Trends Endocrinol Metab. 2009 Jan;20(1):8-15
pubmed: 19019695
BMC Nephrol. 2018 May 21;19(1):117
pubmed: 29783932
Transplant Proc. 2020 Jan - Feb;52(1):383-391
pubmed: 31959353
Biol Pharm Bull. 2019 Jun 1;42(6):886-891
pubmed: 30918132
BMC Pharmacol Toxicol. 2019 Oct 17;20(1):59
pubmed: 31623681
Oncotarget. 2018 Feb 8;9(14):11707-11721
pubmed: 29545931
PLoS One. 2014 Apr 02;9(4):e93663
pubmed: 24695638
Mol Cell Biochem. 2020 Feb;465(1-2):1-11
pubmed: 31792649
Oncol Lett. 2020 Jan;19(1):849-857
pubmed: 31897199
J Lipid Res. 2005 Nov;46(11):2377-87
pubmed: 16106051
J Cancer. 2020 Jan 1;11(1):229-240
pubmed: 31892989
eNeuro. 2015 Aug 13;2(4):
pubmed: 26465008
Am J Physiol Renal Physiol. 2013 May 15;304(10):F1274-82
pubmed: 23467423
Biomed Res Int. 2019 Jan 20;2019:8579619
pubmed: 30800680
Biochem Biophys Res Commun. 2020 Mar 12;523(3):726-732
pubmed: 31948750
J Cancer. 2020 Jan 1;11(3):570-582
pubmed: 31942180
Mol Ther Nucleic Acids. 2019 Sep 6;17:701-713
pubmed: 31422287